by Team Small News | Jun 10, 2025 | Dr Reddy's
Alvotech, a global biopharmaceutical company, and Dr. Reddy’s Laboratories, a leading pharmaceutical company, have announced a partnership to develop a biosimilar for the cancer drug Pembrolizumab. Pembrolizumab, marketed under the brand name Keytruda, is a...
by Team Small News | Jun 8, 2025 | Dr Reddy's
Alvotech, a global biotech company based in Iceland, and Dr. Reddy’s Laboratories, an Indian pharmaceutical firm, have entered into a collaboration and license agreement to co-develop, manufacture, and commercialize a biosimilar candidate to Keytruda...
by Team Small News | Jun 7, 2025 | Dr Reddy's
Alvotech, a biopharmaceutical company, and Dr. Reddy’s Laboratories, a pharmaceutical company, have announced a partnership to develop a biosimilar for the cancer drug pembrolizumab. Pembrolizumab is a monoclonal antibody used to treat various types of cancer,...
by Team Small News | Jun 2, 2025 | Dr Reddy's
The Delhi High Court has issued an ad interim injunction to restrain Dr. Reddy’s Laboratories and its distributor, OneSource Pharma, from selling a weight loss drug in India. This decision comes amid a patent dispute with Glenmark Pharmaceuticals, which claims...
by Team Small News | May 31, 2025 | Dr Reddy's
The Delhi High Court has issued an interim order restricting Indian companies, Reddy’s Laboratories and OneSource Specialty Pharma, from marketing semaglutide, the active ingredient in the weight loss drug Wegovy, in India. The order was made in response to a...
by Team Small News | May 4, 2025 | Dr Reddy's
The Indian pharmaceutical company, Dr. Reddy’s Laboratories, is facing a challenging time due to regulatory issues surrounding one of its key products, Nimesulide. The Drug Technical Advisory Board (DTAB) and the Central Drugs Standard Control Organization...